2024 21 USC 355-2 – Actions for delays of generic drugs and biosimilar biological products

2023 21 USC 355-2 – Actions for delays of generic drugs and biosimilar biological products

2022 21 USC 355-2 – Actions for delays of generic drugs and biosimilar biological products

2021 21 USC 355-2 – Actions for delays of generic drugs and biosimilar biological products

2020 21 USC 355-2 – Actions for delays of generic drugs and biosimilar biological products